Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1963 1
1966 1
1967 1
1969 1
1970 1
1971 2
1972 1
1973 3
1974 3
1975 7
1976 6
1977 4
1978 5
1979 7
1980 7
1981 13
1982 6
1983 6
1984 7
1985 13
1986 8
1987 7
1988 17
1989 12
1990 11
1991 14
1992 16
1993 17
1994 16
1995 25
1996 19
1997 19
1998 44
1999 55
2000 76
2001 64
2002 93
2003 84
2004 109
2005 96
2006 108
2007 144
2008 157
2009 188
2010 203
2011 238
2012 297
2013 330
2014 393
2015 499
2016 482
2017 493
2018 593
2019 737
2020 809
2021 821
2022 789
2023 772
2024 367

Text availability

Article attribute

Article type

Publication date

Search Results

8,089 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Malignant Hepatobiliary Neoplasm"
Page 1
Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation.
Wang K, Wang X, Pan Q, Zhao B. Wang K, et al. Mol Cancer. 2023 Oct 6;22(1):167. doi: 10.1186/s12943-023-01870-3. Mol Cancer. 2023. PMID: 37803304 Free PMC article. Review.
Pancreatic cancer (PC) is one of the most common malignancies. Surgical resection is a potential curative approach for PC, but most patients are unsuitable for operations when at the time of diagnosis. ...
Pancreatic cancer (PC) is one of the most common malignancies. Surgical resection is a potential curative approach for PC, but most p …
Incidence and Prognosis of Primary Gastrinomas in the Hepatobiliary Tract.
Norton JA, Foster DS, Blumgart LH, Poultsides GA, Visser BC, Fraker DL, Alexander HR, Jensen RT. Norton JA, et al. JAMA Surg. 2018 Mar 1;153(3):e175083. doi: 10.1001/jamasurg.2017.5083. JAMA Surg. 2018. PMID: 29365025 Free PMC article.
IMPORTANCE: Zollinger-Ellison syndrome (ZES) is a life-threatening disease caused by a malignant tumor that secretes gastrin (gastrinoma). Gastrinomas typically occur in the pancreas or the duodenum. ...Three patients (43%) remained free of disease at follow-up ranging fro …
IMPORTANCE: Zollinger-Ellison syndrome (ZES) is a life-threatening disease caused by a malignant tumor that secretes gastrin (gastrin …
Imaging of Hepatobiliary Cancer.
Carney BW, Larson MC, Corwin MT, Lamba R. Carney BW, et al. Curr Probl Cancer. 2023 Apr;47(2):100964. doi: 10.1016/j.currproblcancer.2023.100964. Epub 2023 Jun 4. Curr Probl Cancer. 2023. PMID: 37321910 Review.
The liver and biliary tree are common sites of primary and secondary malignancies. MRI followed by CT is the mainstay for the imaging characterization of these malignancies with the dynamically acquired contrast enhanced phases being the most important for diagnosis …
The liver and biliary tree are common sites of primary and secondary malignancies. MRI followed by CT is the mainstay for the imaging …
The clinical significance of elevated levels of serum CA 19-9.
Pavai S, Yap SF. Pavai S, et al. Med J Malaysia. 2003 Dec;58(5):667-72. Med J Malaysia. 2003. PMID: 15190651 Free article.
The tumour marker CA19-9 is a sensitive marker for pancreatic, gastric and hepatobiliary malignancies. High CA 19-9 level indicates unresectable lesions and a poor prognosis. ...A one-year retrospective review of all patients who had CA19-9 measured in our Medical C …
The tumour marker CA19-9 is a sensitive marker for pancreatic, gastric and hepatobiliary malignancies. High CA 19-9 level indi …
Surgical Treatments of Hepatobiliary Cancers.
Gunasekaran G, Bekki Y, Lourdusamy V, Schwartz M. Gunasekaran G, et al. Hepatology. 2021 Jan;73 Suppl 1:128-136. doi: 10.1002/hep.31325. Epub 2020 Nov 26. Hepatology. 2021. PMID: 32438491 Review.
With improved screening for hepatobiliary malignancies in patients with risk factors and with widespread use of laparoscopic cholecystectomy, hepatobiliary malignancies, including incidental diagnosis of gallbladder carcinoma, are on the rise. Definiti …
With improved screening for hepatobiliary malignancies in patients with risk factors and with widespread use of laparoscopic c …
Hepatobiliary Cancers: Progress in Diagnosis, Pathogenesis, and Treatment.
Pant K, Gradilone SA. Pant K, et al. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221097203. doi: 10.1177/15330338221097203. Technol Cancer Res Treat. 2022. PMID: 35546130 Free PMC article.
Hepatobiliary cancers comprise a wide range of malignancies such as hepatocellular carcinoma and cholangiocarcinoma, and they are some of the most challenging to treat human neoplasms. ...Furthermore, surgery is frequently intrusive and linked with a signific …
Hepatobiliary cancers comprise a wide range of malignancies such as hepatocellular carcinoma and cholangiocarcinoma, and they …
Extracellular Vesicles in Hepatobiliary Malignancies.
Lapitz A, Arbelaiz A, Olaizola P, Aranburu A, Bujanda L, Perugorria MJ, Banales JM. Lapitz A, et al. Front Immunol. 2018 Oct 12;9:2270. doi: 10.3389/fimmu.2018.02270. eCollection 2018. Front Immunol. 2018. PMID: 30369925 Free PMC article. Review.
Primary hepatobiliary malignancies include a heterogeneous group of cancers with dismal prognosis, among which hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and hepatoblastoma (HB) stand out. These tumors mainly arise from the malignant transforma …
Primary hepatobiliary malignancies include a heterogeneous group of cancers with dismal prognosis, among which hepatocellular …
Imaging mimickers of cholangiocarcinoma: a pictorial review.
Chiow SM, Khoo HW, Low JK, Tan CH, Low HM. Chiow SM, et al. Abdom Radiol (NY). 2022 Mar;47(3):981-997. doi: 10.1007/s00261-021-03399-9. Epub 2022 Jan 3. Abdom Radiol (NY). 2022. PMID: 34978593 Review.
Cholangiocarcinoma (CCA) is the second most common primary hepatobiliary malignancy and presents as three separate morphological subtypes; namely mass-forming, periductal-infiltrating, and intraductal-growing patterns. Each of these subtypes have distinct imaging ch …
Cholangiocarcinoma (CCA) is the second most common primary hepatobiliary malignancy and presents as three separate morphologic …
Autophagy-mediating microRNAs in cancer chemoresistance.
Jing Y, Liang W, Liu J, Zhang L, Wei J, Yang J, Zhang Y, Huang Z. Jing Y, et al. Cell Biol Toxicol. 2020 Dec;36(6):517-536. doi: 10.1007/s10565-020-09553-1. Epub 2020 Sep 1. Cell Biol Toxicol. 2020. PMID: 32875398 Review.
Advances in targeted therapy of cholangiocarcinoma.
Li Y, Yu J, Zhang Y, Peng C, Song Y, Liu S. Li Y, et al. Ann Med. 2024 Dec;56(1):2310196. doi: 10.1080/07853890.2024.2310196. Epub 2024 Feb 15. Ann Med. 2024. PMID: 38359439 Free PMC article. Review.
Cholangiocarcinoma (CCA) is a malignant tumor originating in the bile duct and its branching epithelium. ...The regimen of gemcitabine combined with platinum has been used as the first-line chemotherapy for advanced patients. In recent years, targeted therapy for a variety …
Cholangiocarcinoma (CCA) is a malignant tumor originating in the bile duct and its branching epithelium. ...The regimen of gemcitabin …
8,089 results